Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TECH – Bio-Techne Corporation

Bio-Techne Corp
TECH
$57.09
Name : Bio-Techne Corp
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $8,949,828,608.00
EPSttm : 0.46
finviz dynamic chart for TECH
Bio-Techne Corp
$57.09
5.72%
$3.09

Float Short %

4.09

Margin Of Safety %

6

Put/Call OI Ratio

0.42

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.23

Price

57.08

Target Price

65.31

Analyst Recom

1.6

Performance Q

20.65

Relative Volume

0.63

Beta

1.47

Ticker: TECH




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25TECH58.780.530.769640
2025-07-28TECH58.590.532.289648
2025-07-29TECH57.870.540.779635
2025-07-30TECH57.740.541.759643
2025-07-31TECH54.720.530.519626
2025-08-01TECH54.90.510.1311214
2025-08-04TECH54.870.490.0611586
2025-08-05TECH54.630.490.2911685
2025-08-06TECH49.880.420.7615416
2025-08-07TECH50.170.411.6915347
2025-08-08TECH50.440.423.6515373
2025-08-11TECH50.160.463.4415790
2025-08-12TECH52.840.460.1115772
2025-08-13TECH54.730.480.2215672
2025-08-14TECH53.750.490.2415685
2025-08-15TECH53.60.492.2315694
2025-08-18TECH53.310.420.0411822
2025-08-19TECH54.880.423.1611833
2025-08-20TECH54.330.420.0611925
2025-08-21TECH54.010.420.0011949
2025-08-22TECH57.080.420.2911990
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25TECH58.782.0185.31.91
2025-07-28TECH58.702.0182.91.91
2025-07-29TECH57.872.0179.41.91
2025-07-30TECH57.712.0182.61.91
2025-07-31TECH54.732.0165.61.91
2025-08-01TECH54.892.0184.51.91
2025-08-04TECH54.882.0183.31.91
2025-08-05TECH54.642.0181.91.91
2025-08-06TECH49.882.0153.41.91
2025-08-07TECH50.152.0185.41.91
2025-08-08TECH50.42-2.4185.31.99
2025-08-11TECH50.15-2.4180.61.99
2025-08-12TECH52.841.4200.82.02
2025-08-13TECH54.711.5194.62.02
2025-08-14TECH53.791.5157.02.02
2025-08-15TECH53.600.9161.62.01
2025-08-18TECH53.300.9160.62.01
2025-08-19TECH54.871.0172.02.01
2025-08-20TECH54.331.0159.22.01
2025-08-21TECH54.011.0160.52.01
2025-08-22TECH57.081.0180.92.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25TECH-0.924.574.21
2025-07-28TECH-0.922.574.21
2025-07-29TECH-0.922.574.21
2025-07-30TECH-0.182.574.21
2025-07-31TECH-0.182.574.21
2025-08-01TECH-0.182.574.21
2025-08-04TECH-0.181.824.21
2025-08-05TECH-0.171.824.21
2025-08-06TECH-0.171.824.21
2025-08-07TECH-0.171.824.21
2025-08-08TECH-0.171.824.21
2025-08-11TECH-0.171.974.21
2025-08-12TECH-0.171.974.09
2025-08-13TECH-0.171.974.09
2025-08-14TECH-0.171.974.09
2025-08-15TECH-0.171.974.09
2025-08-18TECH-0.17-1.614.09
2025-08-19TECH-0.07-1.614.09
2025-08-20TECH-0.07-1.614.09
2025-08-21TECH-0.07-1.614.09
2025-08-22TECH-0.07-1.614.09
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.42

Avg. EPS Est. Next Quarter

0.46

Insider Transactions

-0.07

Institutional Transactions

-1.61

Beta

1.47

Average Sales Estimate Current Quarter

293

Average Sales Estimate Next Quarter

300

Fair Value

60.56

Quality Score

88

Growth Score

82

Sentiment Score

91

Actual DrawDown %

58

Max Drawdown 5-Year %

-64.8

Target Price

65.31

P/E

125.83

Forward P/E

25.27

PEG

10.81

P/S

7.34

P/B

4.43

P/Free Cash Flow

33.92

EPS

0.45

Average EPS Est. Cur. Y​

2.01

EPS Next Y. (Est.)

2.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.02

Relative Volume

0.63

Return on Equity vs Sector %

-18.2

Return on Equity vs Industry %

-5.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.06

EBIT Estimation

180.9
Bio-Techne Corp
Sector: Healthcare
Industry: Biotechnology
Employees: 3100
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
stock quote shares TECH – Bio-Techne Corporation Stock Price stock today
news today TECH – Bio-Techne Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TECH – Bio-Techne Corporation yahoo finance google finance
stock history TECH – Bio-Techne Corporation invest stock market
stock prices TECH premarket after hours
ticker TECH fair value insiders trading